Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A PHASE II TRIAL OF A VACCINE COMBINING MULTIPLE CLASS I PEPTIDES WITH MONTANIDE ISA 51 OR ISA 51 VG AND CpG ADJUVANT 7909 FOR PATIENTS WITH RESECTED STAGES IIC/III AND IV MELANOMA

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00085189
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:41.798684+00:00
Published At
2014-05-22T00:00:00+00:00
Record Updated At
2014-05-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ciliary Body and Choroid Melanoma, Medium/Large Size", "Ciliary Body and Choroid Melanoma, Small Size", "Extraocular Extension Melanoma", "Iris Melanoma", "Metastatic Intraocular Melanoma", "Mucosal Melanoma", "Recurrent Intraocular Melanoma", "Recurrent Melanoma", "Stage IIC Melanoma", "Stage IIIA Intraocular Melanoma", "Stage IIIA Melanoma", "Stage IIIB Intraocular Melanoma", "Stage IIIB Melanoma", "Stage IIIC Intraocular Melanoma", "Stage IIIC Melanoma", "Stage IV Intraocular Melanoma", "Stage IV Melanoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-05-22"
protocolSection.identificationModule.nctId
"NCT00085189"
protocolSection.identificationModule.officialTitle
"A PHASE II TRIAL OF A VACCINE COMBINING MULTIPLE CLASS I PEPTIDES WITH MONTANIDE ISA 51 OR ISA 51 VG AND CpG ADJUVANT 7909 FOR PATIENTS WITH RESECTED STAGES IIC/III AND IV MELANOMA"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ciliary Body and Choroid Melanoma, Medium/Large Size (protocolSection.conditionsModule.conditions)
  • Ciliary Body and Choroid Melanoma, Small Size (protocolSection.conditionsModule.conditions)
  • Extraocular Extension Melanoma (protocolSection.conditionsModule.conditions)
  • Iris Melanoma (protocolSection.conditionsModule.conditions)
  • Metastatic Intraocular Melanoma (protocolSection.conditionsModule.conditions)
  • Mucosal Melanoma (protocolSection.conditionsModule.conditions)
  • Recurrent Intraocular Melanoma (protocolSection.conditionsModule.conditions)
  • Recurrent Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIC Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Intraocular Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIIA Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIIB Intraocular Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIIB Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIIC Intraocular Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IIIC Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IV Intraocular Melanoma (protocolSection.conditionsModule.conditions)
  • Stage IV Melanoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.